Medivir
A pharmaceutical company developing innovative drugs for cancer.
MVIR | ST
Overview
Corporate Details
- ISIN(s):
- SE0000325151 (+4 more)
- LEI:
- 549300VWDGUX0WMJ1T79
- Country:
- Sweden
- Address:
- Box 1086, 141 22 Huddinge
- Website:
- https://www.medivir.com/
- Sector:
- Manufacturing
Description
Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-08 07:30 |
Medivirs finanschef Magnus Christensen lämnar bolaget
|
Swedish | 47.6 KB | ||
| 2025-12-08 07:30 |
Medivir’s CFO Magnus Christensen to leave the company
|
English | 46.6 KB | ||
| 2025-12-03 21:00 |
Medivir offentliggör utfallet i företrädesemissionen
|
Swedish | 61.6 KB | ||
| 2025-12-03 21:00 |
Medivir announces the outcome of the Rights Issue
|
English | 63.4 KB | ||
| 2025-11-18 18:19 | Swedish | 10.3 KB | |||
| 2025-11-14 08:30 |
Medivir offentliggör informationsdokument avseende företrädesemission
|
Swedish | 55.9 KB | ||
| 2025-11-14 08:30 |
Medivir publishes disclosure document regarding rights issue
|
English | 57.5 KB | ||
| 2025-11-10 15:00 |
BULLETIN FROM EXTRAORDINARY GENERAL MEETING in MEDIVIR AB (PUBL)
|
English | 51.4 KB | ||
| 2025-11-10 15:00 |
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I MEDIVIR AB (PUBL)
|
Swedish | 51.2 KB | ||
| 2025-11-06 08:30 | Swedish | 391.5 KB | |||
| 2025-11-06 08:30 | English | 332.8 KB | |||
| 2025-10-23 08:30 |
Medivir tecknar exklusivt licensavtal med Biossil, Inc. för remetinostat
|
Swedish | 50.3 KB | ||
| 2025-10-23 08:30 |
Medivir enters exclusive licensing agreement with Biossil, Inc. for remetinostat
|
English | 49.9 KB | ||
| 2025-10-08 09:15 |
Kallelse till extra bolagsstämma i Medivir AB (publ)
|
Swedish | 80.7 KB | ||
| 2025-10-08 09:15 |
Notice of Extraordinary General Meeting of Medivir AB (publ)
|
English | 82.0 KB |
Automate Your Workflow. Get a real-time feed of all Medivir filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medivir
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medivir via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-11-15 | Fredrik Öberg | Other | Buy | 100,000 | 77,000.00 SEK |
| 2022-11-14 | Jens Anders Fredrik Lindberg | Other | Buy | 250,000 | 192,500.00 SEK |
| 2022-11-14 | Magnus Christensen | Other | Buy | 150,000 | 115,500.00 SEK |
| 2022-03-28 | Jens Anders Fredrik Lindberg | Other | Buy | 15,000 | 122,850.00 SEK |
| 2022-03-25 | Jens Anders Fredrik Lindberg | Other | Buy | 10,000 | 80,000.00 SEK |
| 2022-03-03 | Magnus Christensen | Other | Buy | 6,000 | 46,800.00 SEK |
| 2021-12-23 | Malene Jensen | Other | Buy | 15,000 | 25,650.00 SEK |
| 2021-12-13 | Malene Jensen | Other | Buy | 50,000 | 109,500.00 SEK |
| 2021-12-13 | Malene Jensen | Other | Buy | 50,000 | 85,500.00 SEK |
| 2021-05-13 | Fredrik Öberg | Other | Buy | 97,500 | 97,500.00 SEK |
Peer Companies
